Abstract：
BACKGROUND:Microarray gene-profiling of invasive breast cancer has identified different subtypes including luminal A, luminal B, HER2-overexpressing and basal-like groups. Basal-like invasive breast cancer is associated with a worse prognosis. However, the prognosis of basal-like ductal carcinoma in situ (DCIS) is still unknown. Our aim was to study the prognosis of basal-like DCIS in a large population-based cohort. METHODS:All 458 women with a primary DCIS diagnosed between 1986 and 2004, in Uppland and Västmanland, Sweden were included. TMA blocks were constructed. To classify the DCIS tumors, we used immunohistochemical (IHC) markers (estrogen-, progesterone-, HER2, cytokeratin 5/6 and epidermal growth factor receptor) as a surrogate for the gene expression profiling. The association with prognosis was examined for basal-like DCIS and other subtypes using Kaplan-Meier survival analyses and Cox proportional hazards regression models. RESULTS:IHC data were complete for 392 women. Thirty-two were basal-like (8.2%), 351 were luminal or HER2-positive (89.5%) and 9 unclassified (2.3%). Seventy-six women had a local recurrence of which 34 were invasive. Another 3 women had general metastases as first event. Basal-like DCIS showed a higher risk of local recurrence and invasive recurrence 1.8 (Confidence interval (CI) 95%, 0.8-4.2) and 1.9 (0.7-5.1), respectively. However, the difference was not statistically significant. Also, no statistically significant increased risk was seen for triple-negative or high grade DCIS. CONCLUSIONS:Basal-like DCIS showed about a doubled, however not statistically significant risk for local recurrence and developing invasive cancer compared with the other molecular subtypes. Molecular subtyping was a better prognostic parameter than histopathological grade.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Zhou W,Jirström K,Johansson C,Amini RM,Blomqvist C,Agbaje O,Wärnberg Fdoi
10.1186/1471-2407-10-653subject
Has Abstractpub_date
2010-11-30 00:00:00pages
653issn
1471-2407pii
1471-2407-10-653journal_volume
10pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:The transcription factor nuclear factor erythroid 2-related factor 2 (NFE2L2; previously known as NRF2) is a crucial regulator of the intracellular antioxidant response. It controls the expression of genes involved in the detoxification and elimination of reactive oxidants and electrophilic agents. The role ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2840-x
更新日期：2016-10-22 00:00:00
abstract：BACKGROUND:Cancer stem cells (CSCs) are thought to play important roles in therapy-resistance. In this study, we induced cancer stem-like cells from hepatocellular carcinoma (HCC) cell lines using a unique medium, and examined their potential for resistance to anti-cancer drugs. METHODS:The human HCC cell lines SK-HEP...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-722
更新日期：2014-09-27 00:00:00
abstract：BACKGROUND:There is currently limited information regarding the prognostic ability of the dNLR-PNI (the combination of the derived neutrophil-to-lymphocyte ratio [dNLR] and prognostic nutritional index [PNI]) for hepatocellular carcinoma (HCC). This study aimed to assess the predictive ability of the dNLR-PNI in patien...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4121-3
更新日期：2018-02-21 00:00:00
abstract：BACKGROUND:Classical in vitro wound-healing assays and other techniques designed to study cell migration and invasion have been used for many years to elucidate the various mechanisms associated with metastasis. However, many of these methods are limited in their ability to achieve reproducible, quantitative results th...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-198
更新日期：2008-07-14 00:00:00
abstract：BACKGROUND:MicroRNA-148b (miR-148b) has been detected in various types of tumors, and is generally viewed as a tumor suppressor. Our previous study found the decreased expression of miR-148b in human non small cell lung cancer (NSCLC) specimens and cell lines. However, the underlying mechanisms of miR-148b in regulatin...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5400-3
更新日期：2019-03-08 00:00:00
abstract：BACKGROUND:Fast-track colonoscopy to detect patients with colorectal cancer based on high-risk symptoms is associated with low sensitivity and specificity. The aim was to derive a predictive score of advanced colonic neoplasia in symptomatic patients in fast-track programs. METHODS:All patients referred for fast-track...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/s12885-019-5926-4
更新日期：2019-07-25 00:00:00
abstract：BACKGROUND:Up to 80% of breast cancer patients suffer from Cancer Related Cognitive Impairments (CRCI). Exercise is suggested as a potential supportive care option to reduce cognitive decline in cancer patients. This study will investigate the effects of a high-intensity interval endurance training (HIIT) on CRCI in br...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/s12885-018-4992-3
更新日期：2018-11-06 00:00:00
abstract：BACKGROUND:Several stromal cell subtypes including macrophages contribute to tumor progression by inducing epithelial-mesenchymal transition (EMT) at the invasive front, a mechanism also linked to metastasis. Tumor associated macrophages (TAM) reside mainly at the invasive front but they also infiltrate tumors and in t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-35
更新日期：2012-01-24 00:00:00
abstract：BACKGROUND:Mammalian target of rapamycin (mTOR) inhibitors have anti-tumor effects against renal cell carcinoma, pancreatic neuroendocrine cancer and breast cancer. In this study, we analyzed the antitumor effects of mTOR inhibitors in small cell lung cancer (SCLC) cells and sought to clarify the mechanism of resistanc...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1202-4
更新日期：2015-04-09 00:00:00
abstract：BACKGROUND:To investigate the diagnostic reliability of selective microdochectomy after direct ductoscopic wire marking of suspect lesions in patients with pathological nipple discharge. METHODS:Selective microdochectomy due to pathological discharge was performed in 33 patients with mean age of 51.7 years. Ductoscope...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-151
更新日期：2009-05-17 00:00:00
abstract：BACKGROUND:The association of nipple discharge with breast carcinoma has resulted in numerous women undergoing exploratory surgery to exclude malignancy. The aim of this study was to determine whether pre-operative factors can identify those patients that are most at risk of carcinoma. METHODS:All patients over a 14-y...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-164
更新日期：2006-06-23 00:00:00
abstract：BACKGROUND:For most patients, pancreatic adenocarcinoma responds poorly to treatment, and novel therapeutic approaches are needed. Standard-of-care paclitaxel (PTX), combined with birinapant (BRP), a bivalent mimetic of the apoptosis antagonist SMAC (second mitochondria-derived activator of caspases), exerts synergisti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07398-9
更新日期：2020-10-23 00:00:00
abstract：BACKGROUND:One of the basic prerequisites for generating evidence-based data is the availability of classification systems. Attempts to date to classify breast cancer operations have focussed on specific problems, e.g. the avoidance of secondary corrective surgery for surgical defects, rather than taking a generic appr...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-108
更新日期：2009-04-08 00:00:00
abstract：BACKGROUND:The serine-threonine kinase AKT1 plays essential roles during normal mammary gland development as well as the initiation and progression of breast cancer. AKT1 is generally considered a ubiquitously expressed gene, and its persistent activation is transcriptionally controlled by regulatory elements character...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-195
更新日期：2014-03-15 00:00:00
abstract：BACKGROUND:Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that activation of AMP-acti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-327
更新日期：2013-07-03 00:00:00
abstract：BACKGROUND:High-grade serous ovarian cancer is a detrimental disease. Treatment options in patients with a recurrent disease are dependent on BRCA1/2 mutation status since only patients with known BRCA mutation are eligible for treatment with poly(ADP-ribose) polymerase inhibitors (PARPi). The aim of this study was to ...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/s12885-019-5535-2
更新日期：2019-04-02 00:00:00
abstract：BACKGROUND:Recent randomized controlled trials comparing neoadjuvant chemoradiation plus surgery or perioperative chemotherapy plus surgery with surgery alone showed significant survival benefits for combined modality treatment of patients with localized esophageal adenocarcinoma. However, head-to-head comparisons of n...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-016-2564-y
更新日期：2016-07-19 00:00:00
abstract：BACKGROUND:Given their frequency of occurrence in the United States, cancer and heart disease often coexist. For patients requiring open-heart surgery, this raises concern that the use of cardiopulmonary bypass (CPB) may cause a transient immunosuppression with the potential to promote the spread and growth of coexisti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-519
更新日期：2013-11-03 00:00:00
abstract：BACKGROUND:Gastrointestinal stromal tumors (GIST), one of the most common mesenchymal tumors of the gastrointestinal tract, prior to routine immunohistochemical staining and the introduction of tyrosine kinase inhibitors, were often mistaken for neoplasms of smooth muscle origin such as leiomyomas, leiomyosarcomas or l...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-90
更新日期：2012-03-19 00:00:00
abstract：BACKGROUND:The purpose of this review is to update previously published reviews on exercise programming in exercise trials in prostate cancer survivors. We evaluated: 1) the application of the principles of exercise training in prescribed programs; 2) the reporting of the components of the exercise prescription; and 3)...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5520-9
更新日期：2019-04-05 00:00:00
abstract：BACKGROUND:Despite the increase in cancer incidence in the last years in Serbia, no nation-wide, population-based cancer epidemiology data have been reported. In this study cancer incidence and mortality rates for Serbia are presented using nation-wide data from two population-based cancer registries. These rates are a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-18
更新日期：2013-01-15 00:00:00
abstract：BACKGROUND:High resolution anoscopy (HRA) examination is regarded as the best method for the management of anal high grade squamous intraepithelial lesions to prevent anal squamous carcinoma. However, little is known about the acceptability of this procedure. This analysis looks at patient experience of HRA examination...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4475-6
更新日期：2018-05-11 00:00:00
abstract：BACKGROUND:Myeloid-derived suppressor cells (MDSCs) is a heterogeneous population of immature myeloid cells, inhibiting both the innate and adaptive immunity. Recent studies validated that MDSCs caused immune suppression and promoted cancer progression through various mechanisms. However, the prognostic value of MDSCs ...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-018-5086-y
更新日期：2018-12-05 00:00:00
abstract：BACKGROUND:Clinical trials where cancer patients were treated with protease inhibitors have suggested that the serine protease, prostasin, may act as a tumour suppressor. Prostasin is proteolytically activated by the serine protease, matriptase, which has a very high oncogenic potential. Prostasin is inhibited by prote...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-201
更新日期：2009-06-25 00:00:00
abstract：BACKGROUND:To report a case of metastatic hepatocholangiocarcinoma to the vitreous and retina. CASE PRESENTATION:A 70-year-old male, who was recently diagnosed with hepatocholangiocarcinoma, was complaining of floaters in his right eye over the past 5 months and was referred to the Liverpool Ocular Oncology Centre. On...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3429-8
更新日期：2017-06-19 00:00:00
abstract：BACKGROUND:Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic cancer. N,N'-dinitrosopiperazine (DNP), a carcinogen with specificity for nasopharyngeal epithelium, facilitates NPC metastasis. However, the underlying mechanism is not known. METHODS:Quantitative phosphoproteomics, using stable isotope lab...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-243
更新日期：2014-04-05 00:00:00
abstract：BACKGROUND:Hemostatic alterations occur during the development of cancer. Plasma D-dimer is a hypercoagulability and fibrinolytic system marker that is increased in patients with various solid tumours. The aim of this study was to evaluate the hemostatic status of nasopharyngeal carcinoma (NPC) patients by assessing pl...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-583
更新日期：2014-08-10 00:00:00
abstract：BACKGROUND:Wilms' tumor is also called nephroblastoma and is the most common pediatric renal cancer. Several genetic and epigenetic factors have been found to account for the development of Wilms' tumor. MiRNAs play important roles in this tumorigenic process. In the present study, we aimed to investigate the role of m...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5609-1
更新日期：2019-04-29 00:00:00
abstract：BACKGROUND:Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigate the efficacy of SABR for pr...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4916-2
更新日期：2018-10-23 00:00:00
abstract：BACKGROUND:Methylation of promoter region is the major mechanism affecting gene expression in tumors. Recent methylome studies of brain tumors revealed a list of new epigenetically modified genes. Our aim was to study promoter methylation of newly identified epigenetically silenced genes together with already known epi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-218
更新日期：2012-06-06 00:00:00
